Emine Uslu Yurteri
Overview
Explore the profile of Emine Uslu Yurteri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aksoy R, Turgay T, Yilmaz R, Sezer S, Yayla M, Uslu Yurteri E
Reumatol Clin (Engl Ed)
. 2024 Jul;
20(6):287-290.
PMID: 38991821
Introduction And Objectives: In this study, we aimed to evaluate LIF levels and its possible relationship with disease activity in patients with Takayasu's (TAK) and Giant cell arteritis (GCA) patients....
2.
Uslu Yurteri E, Sezer S, Torgutalp M, Yayla M, Sahin Eroglu D, Okatan I, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2023 Jun;
40(2):e2023015.
PMID: 37382076
Background: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare autoimmune disease usually involving small vessels and progressing with necrotizing inflammation. Treatment requires long-term use of immunosuppressive agents to inhibit...
3.
Yayla M, Uslu Yurteri E, Torgutalp M, Sahin Eroglu D, Sezer S, Kelesoglu Dincer A, et al.
Turk J Med Sci
. 2023 Mar;
52(6):1881-1888.
PMID: 36945989
Background: Systemic sclerosis (SSc) is a chronic systemic disease characterized by vascular damage, autoimmunity, and fibrosis in the skin and internal organs. In this study, we tried to determine the...
4.
Aydemir Guloksuz E, Sezer S, Yayla M, Sahin Eroglu D, Uslu Yurteri E, Kelesoglu Dincer A, et al.
J Clin Rheumatol
. 2023 Mar;
29(4):177-182.
PMID: 36881834
Objective: The aims of this study were to compare the frequency of Helicobacter pylori between patients with rheumatoid arthritis (RA) with and without methotrexate (MTX)-related gastrointestinal system (GIS) intolerance, and...
5.
Yayla M, Sahin Eroglu D, Uslu Yurteri E, Kelesoglu Dincer A, Sezer S, Aydemir Guloksuz E, et al.
Clin Rheumatol
. 2022 Jan;
41(5):1457-1463.
PMID: 34988683
Objective: In this study, it was aimed to reveal the hospitalization reasons for patients diagnosed with primary Sjögren syndrome (pSS) and potentially associated factors in a tertiary health center. Method:...
6.
Torgutalp M, Sahin Eroglu D, Sezer S, Yayla M, Karatas G, Uslu Yurteri E, et al.
Joint Bone Spine
. 2021 Sep;
89(2):105277.
PMID: 34536626
Objectives: To describe demographic and clinical characteristics of vascular involvement in patients with Behçet's syndrome (BS) and to evaluate associations with such involvement. Methods: We retrospectively evaluated records of 2118...
7.
Torgutalp M, Yayla M, Sahin Eroglu D, Kelesoglu Dincer A, Uslu Yurteri E, Okatan I, et al.
Mediterr J Rheumatol
. 2021 Aug;
32(1):56-65.
PMID: 34386702
Objective: Calprotectin is an inflammatory biomarker which assesses disease activity in rheumatoid arthritis (RA). The objective of this study was to test whether serum calprotectin is associated with clinical and...
8.
Uslu Yurteri E, Ustuner E, Torgutalp M, Yayla M, Okatan I, Sezer S, et al.
J Clin Rheumatol
. 2021 Jul;
28(1):e73-e76.
PMID: 34321437
Objective: Behçet syndrome (BS) is a multisystemic chronic vasculitic disease. Among previous studies, although there are some that showed increased risk of subclinical atherosclerosis in BS, there are also others...
9.
Yayla M, Torgutalp M, Okatan I, Uslu Yurteri E, Kucuksahin O, Kelesoglu Dincer A, et al.
J Clin Rheumatol
. 2018 Nov;
26(3):83-86.
PMID: 30431486
Background/objective: Interleukin (IL) 35 is a member of the IL-12 family. Studies show that IL-35 is an important anti-inflammatory cytokine and suppresses effector T-cell activity. In this study, we aimed...